8-K: American Healthcare REIT Announces Third Quarter 2024 Distribution and Provides Portfolio Update

American Healthcare REIT declared a $0.25 per share quarterly distribution and released an investor presentation highlighting strong portfolio performance and growth opportunities.

Summary

• American Healthcare REIT (AHR) has announced a third quarter 2024 distribution of $0.25 per share, equating to an annualized rate of $1.00 per share.
• The distribution is payable in cash on or about October 18, 2024, to shareholders of record as of September 20, 2024.
• AHR also released an investor presentation detailing its second quarter 2024 performance, including a 15.7% same-store NOI growth and a 7.3% same-store revenue growth.
• The company has increased its full-year 2024 same-store NOI growth guidance for the total portfolio to 12.0% 14.0%.
• AHR's net-debt-to-annualized adjusted EBITDA improved to 5.9x as of June 30, 2024, from 6.4x as of March 31, 2024.
• The company acquired a portfolio of 242 senior housing units in Washington on September 3, 2024, for $36.2 million, with an expected low double-digit NOI yield within 12 months.
• AHR has a purchase option for the remaining minority share of Trilogy, exercisable until September 2025, with a fixed price of $247 million if closed by December 31, 2024, or $260 million thereafter.

Sentiment

Score: 8

Explanation: The document presents a very positive outlook with strong financial results, increased guidance, and strategic growth initiatives. The company's performance metrics are impressive, and the management team appears experienced and capable. The potential capital raise is structured in a way that provides flexibility and could be accretive to shareholders.

Positives

• The company's distribution of $0.25 per share provides a solid return for investors.
• Strong same-store NOI and revenue growth indicate robust operational performance.
• Increased full-year guidance suggests management's confidence in continued growth.
• The improvement in net-debt-to-annualized adjusted EBITDA demonstrates a strengthening balance sheet.
• Strategic acquisitions, such as the Washington portfolio, are expected to drive future growth.
• The Trilogy purchase option provides a clear path to full ownership of a high-performing asset.
• The company's RIDEA structure allows it to directly benefit from operational improvements.
• AHR has a diversified portfolio across different healthcare sectors, reducing risk.
• The company has a strong management team with extensive experience in healthcare real estate.
• The company is well-positioned to capitalize on favorable senior housing demographics and limited new supply.

Negatives

• The Outpatient Medical segment is experiencing slower leasing activity after a strong 2023.
• The company's financial results are subject to risks and uncertainties, as disclosed in SEC filings.
• The company's non-GAAP financial measures may not be comparable to those of other REITs.
• The company's reliance on tenant-provided data for some metrics may introduce inaccuracies.
• The company's future performance is subject to market conditions and other external factors.

Risks

• The company's forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.
• The company's performance is dependent on the operational success of its tenants and operators.
• Changes in healthcare regulations or reimbursement policies could negatively impact the company's business.
• The company's ability to execute its growth strategy is subject to market conditions and competition.
• The company's debt levels and interest rate exposure could pose risks in a rising interest rate environment.
• The company's reliance on non-GAAP financial measures may obscure underlying financial performance.
• The company's acquisition strategy may expose it to integration risks and unforeseen challenges.
• The company's development pipeline may be subject to delays and cost overruns.
• The company's ability to maintain high occupancy rates is subject to market demand and competition.
• The company's reliance on a few key operators could pose a risk if those operators underperform.

Future Outlook

The company anticipates continued growth in senior housing due to favorable demographics and limited new supply, and expects to capitalize on organic growth opportunities and strategic acquisitions. AHR also expects to benefit from improving labor costs and inflation trends. The company is targeting an investment grade rating over time.

Management Comments

• Management is focused on high-quality outcomes for care received in the company's properties.
• The management team has a proven track record of strategic capital allocation and portfolio expansion.
• Management is committed to excellence and has a deep bench of leaders with relevant experience.
• Management is focused on acquisition pricing, execution, and structuring for strong performance and proper alignment.

Industry Context

The announcement aligns with the broader trend of increasing demand for senior housing and healthcare facilities, driven by an aging population. The company's focus on RIDEA structures and strategic acquisitions positions it to benefit from these trends. The limited new supply in the senior housing sector also creates a favorable environment for existing operators.

Comparison to Industry Standards

• AHR's same-store NOI growth of 15.7% in Q2 2024 significantly outperforms the average of its healthcare REIT peers, which include WELL, VTR, and SBRA.
• AHR's ISHC segment reported a 24.1% same-store NOI growth, while its SHOP segment reported a 49.1% same-store NOI growth, both of which are sector-leading.
• The company's occupancy rates in its ISHC and SHOP segments are also higher than the average of its healthcare REIT peers.
• AHR's focus on a RIDEA structure is similar to other healthcare REITs that operate senior housing properties, but AHR's performance metrics suggest a more effective implementation.
• The company's acquisition of the Washington portfolio at a high single-digit going-in NOI yield, expected to stabilize at a low double-digit yield, is in line with industry standards for distressed asset acquisitions.
• The company's use of HUD debt with a 3.6% fixed interest rate and a 28.6-year term is a common strategy among healthcare REITs to secure long-term, low-cost financing.

Corporate Governance

Stakeholder Impact

• Shareholders will benefit from the quarterly distribution and potential for future growth.
• Employees will benefit from the company's commitment to a diversified workplace and robust benefit programs.
• Customers (residents) will benefit from the company's focus on high-quality care standards.
• Operators will benefit from the company's long-term partnerships and alignment of goals.
• Creditors will benefit from the company's deleveraging efforts and improved financial position.

Next Steps

• The company will pay the third quarter distribution on or about October 18, 2024.
• The company will continue to execute on its growth strategy, including strategic acquisitions and development projects.
• The company will evaluate the option to purchase the remaining minority share of Trilogy.
• The company will continue to focus on improving operational performance and reducing debt levels.

Key Dates

Keywords

Healthcare REIT, Senior Housing, Real Estate Investment Trust, Outpatient Medical, Distribution, NOI Growth, Same-Store, Trilogy, RIDEA, Acquisition, Occupancy, EBITDAR, Debt, Development